Switzerland · Investor

BioMedPartners

Last cheque observed Dec 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

QuietPrivate equity

SeedSeries ASeries BLife SciencesBiotech

Cheques on record
0%of best year0cheques in 12 months, 25 on record
Since the last cheque2517days00hrs00min00sec
Median round$16MRounds led2 of 25Sole investor1 roundsExits2 from the portfolioMostly inSwitzerland, 52%
Pitch BioMedPartners

BioMedPartners highlights

  1. 01

    25 rounds on record

  2. 02

    Mostly Series A and Series B: 72% of its rounds

  3. 03

    Sole investor in 1 rounds, median $14M

  4. 04

    2 exits from the portfolio

What they do

BiomedVC was founded in 2021 to continue the legacy of BioMedPartners by empowering the next generation of Life Science entrepreneurs ... We support ... with initial investments in Seed and Series A stages.From their own website
Type
Private equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
Life SciencesBiotech
Based in
Basel, Switzerland
Cold pitches
Not stated

The record

Every round we can evidence, newest first25 appearances

  1. 2019

    2 rounds

  2. Dec
    ImmunOSSeries A · CH · FinSMEs$15MLed
  3. May
    Alentis TherapeuticsSeries A · CH · FinSMEs$13MLed
  4. 2018

    1 round

  5. Nov
    Camel-IDSSeries A · BE · Healthcap$42MWith 5 others
  6. 2017

    1 round

  7. May
    Cardior PharmaceuticalsSeries A · DE · FinSMEs$16MWith 4 others
  8. 2014

    3 rounds

  9. Dec
    AYOXXA BiosystemsSeed · DE$14MSole investor
  10. Oct
    ImevaXSeries A · DE$9.5MWith 3 others
  11. Apr
    Sequana MedicalSeries C · CH$26MWith 5 others
  12. 2013

    4 rounds

  13. Nov
    Delenex TherapeuticsSeries A · CH · startupticker.ch$8.0MWith 4 others
  14. Nov
    Hookipa BiotechSeries B · AT · finsmes.com$26MWith 4 others
  15. Oct
    Middle Peak MedicalSeries A · US · finsmes.com$3.0MWith 4 others
  16. May
    SuppreMolSeries D · DE · pevc.dowjones.com$12MWith 3 others
  17. 2012

    1 round

  18. May
    SpinelabSeries C · CH · pehub.com$4.9MWith 1 other
  19. 2011

    4 rounds

  20. May
    Delenex TherapeuticsSeries A · CH · finsmes.com$19MWith 5 others
  21. Mar
    AnergisSeries A · CH · fiercebiotech.com$20MWith 2 others
  22. Mar
    NovaShuntSeries B · CH · prnewswire.com$25MWith 4 others
  23. Feb
    ActivaeroSeries A · DE · cnbc.com$6.8MWith 5 others
  24. 2010

    3 rounds

  25. Dec
    SuppreMolSeries C · DE · finsmes.com$21MWith 5 others
  26. Nov
    Delenex TherapeuticsSeries A · CH · finsmes.com$14MWith 4 others
  27. Apr
    Affimed TherapeuticsSeries C · DE · fiercebiotech.com$27MWith 2 others
  28. 2009

    3 rounds

  29. Dec
    EvolvaSeries B · CH · onbiovc.com$28MWith 7 others
  30. Dec
    CuretisSeries A · DE · curetis.com$28MWith 3 others
  31. Nov
    ActivaeroSeries A · DE · businesswire.com$16MWith 3 others
  32. 2008

    1 round

  33. Aug
    ESBATechSeries B · CH · fiercebiotech.com$22MWith 7 others
  34. 2007

    1 round

  35. Oct
    idiagVenture · CH$3.8MWith 2 others
  36. 2006

    1 round

  37. Aug
    ESBATechSeries B · CH · esbatech.com$41MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

SuppreMolBought by Baxter InternationalUndisclosedMar 2015
ActivaeroBought by VecturaUndisclosedMar 2014

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as BioMedPartners. A count of rooms they were both in, not a relationship either has claimed.

VI PartnersVC firm10rounds togetherHBM BioVenturesGrowth equity5rounds togetherSV Life SciencesVC firm5rounds togetherHBM BioCapitalInvestment firm4rounds togetherEQT life sciencePrivate equity3rounds togetherEntrepreneurs FundVC firm3rounds togetherNovartis Venture FundCorporate VC3rounds togetherWellington PartnersVC firm3rounds togetherAbalis FinanceVC firm2rounds togetherAeris CapitalGrowth equity2rounds togetherCapricorn PartnersVC firm2rounds togetherClarus VenturesVC firm2rounds together

Recently backed

The latest companies BioMedPartners put money into.

Alentis Therapeutics$13M · May 2019Cardior Pharmaceuticals$16M · May 2017

Quick answers about BioMedPartners

What does BioMedPartners invest in?

BioMedPartners invests most often at Series A and Series B (72% of the rounds on record), in sectors such as Life Sciences and Biotech.

How active is BioMedPartners?

25 investments on record, 0 of them in the last 12 months, and it led 2. The most recent was in Dec 2019.

What has BioMedPartners invested in recently?

Its most recent investments on record: ImmunOS (Series A, Dec 2019), Alentis Therapeutics (Series A, May 2019) and Camel-IDS (Series A, Nov 2018).

How big are BioMedPartners's cheques?

The median round it joins is $16M.

Does BioMedPartners lead rounds?

Sometimes: it led 2 of its 25 investments on record (8%).

Where does BioMedPartners invest?

Most of the companies it backs are in Switzerland (52%) and Germany (36%).

Is BioMedPartners investing now?

No investments in the last 12 months; the latest was in Dec 2019.

Who does BioMedPartners invest alongside?

Most often VI Partners (10 rounds together), HBM BioVentures (5 rounds together) and SV Life Sciences (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it